Two lots of migraine medication have been recalled

10:07 EDT 19 Aug 2019 | European Pharmaceutical Review

Pfizer has volountarily recalled the migraine medication Relpax because of the potential presence of Genus Pseudomonas and Burkholderia.

The post Two lots of migraine medication have been recalled appeared first on European Pharmaceutical Review.

Original Article: Two lots of migraine medication have been recalled

More From BioPortfolio on "Two lots of migraine medication have been recalled"